Aclaris Therapeutics Stock Forecast
Aclaris Therapeutics stock upgraded to Hold/Accumulate.
(Updated on Apr 25, 2024)
The Aclaris Therapeutics stock price gained 1.71% on the last trading day (Thursday, 25th Apr 2024), rising from $1.17 to $1.19. During the last trading day the stock fluctuated 7.46% from a day low at $1.14 to a day high of $1.23. The price has risen in 4 of the last 10 days but is still down by -2.46% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 303 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $1.92 million.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Aclaris Therapeutics stock with a 90% probability to be traded between $1.09 and $1.47 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ACRS Signals & Forecast
Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aclaris Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.21 and $1.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -5.56%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Aclaris Therapeutics stock
Aclaris Therapeutics finds support from accumulated volume at $1.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.0850 (7.46%) between high and low. For the last week, the stock has had daily average volatility of 5.06%.
Our recommended stop-loss: $1.14 (-4.22%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 18 days ago.)
Trading Expectations (ACRS) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Aclaris Therapeutics to open at $1.19, and during the day (based on 14 day Average True Range), to move between $1.12 and $1.26, which gives a possible trading interval of +/-$0.0678 (+/-5.70%) up or down from last closing price. If Aclaris Therapeutics takes out the full calculated possible swing range there will be an estimated 11.40% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.21 (1.68%) than the support at $1.17 (1.68%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Aclaris Therapeutics stock A Buy?
Aclaris Therapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.
Current score: -0.971 Hold/Accumulate Upgraded
Predicted Opening Price for Aclaris Therapeutics of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $1.19 ( 0.420%) | $1.19 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ACRS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.27 | 6.72 % | |
| R2 | 1.24 | 3.99 % | ||
| R1 | 1.22 | 2.31 % | ||
| Current price: | 1.19 | |||
| Support | S1 | 1.15 | -3.15 % | |
| S2 | 1.13 | -4.83 % | ||
| S3 | 1.10 | -7.56 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.23 | 3.36 % | |
| R2 | 1.22 | 2.52 % | ||
| R1 | 1.21 | 1.68 % | ||
| Current price | 1.19 | |||
| Support | S1 | 1.17 | -1.68% | |
| S2 | 1.15 | -3.36% | ||
| S3 | 1.06 | -10.92% |
FAQ
Click here for our free guide on how to buy Aclaris Therapeutics Stock.
